We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04437511
Brief Title: A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
First Submitted : June 17, 2020
First Submitted that Met QC Criteria : June 17, 2020
First Posted : June 18, 2020
Last Update Submitted that Met QC Criteria : May 16, 2023
Last Update Posted : May 17, 2023